Hypoglycemia Following a Nateglinide Overdose in a Suicide Attempt

  1. Shiho Nakayama, MD,
  2. Takahisa Hirose, MD,
  3. Hirotaka Watada, MD,
  4. Yasushi Tanaka, MD and
  5. Ryuzo Kawamori, MD
  1. From the Department of Medicine, Metabolism and Endocrinology, Juntendo University School of Medicine, Tokyo, Japan
  1. Address correspondence to Dr. Takahisa Hirose, Department of Medicine, Juntendo University School of Medicine, 2-1-1 Hongo, Tokyo 113-8421, Japan. E-mail: hirosemd{at}med.juntendo.ac.jp

Various drugs are currently used for the treatment of diabetes. Several reports on overdose of these drugs, especially on sulfonylurea and metformin, have been published (1,2); however, few such publications are available on nateglinide, a rapid insulin secreatagogue. We report the first case of attempted suicide by nateglinide overdose. A 30-year-old Japanese nondiabetic woman was transferred to the emergency department of our hospital 1 h after (6:30 a.m.) ingesting 3,420 mg (38 tablets, 90 mg each) of nateglinide, which was prescribed to her diabetic partner. She had a mild psychiatric history and used minor tranquilizers occasionally. Upon arrival to the hospital, she was able to …

« Previous | Next Article »Table of Contents